Catalyst Wire Dossier Catalyst Wire Dossier

MedJ-01 Ridaforolimus-eluting coronary stent system (JNIR)

ridaforolimus-eluting coronary stent system · Medinol Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MedJ-01 Ridaforolimus-eluting coronary stent system (JNIR), covering 2020-09-24 to 2020-09-24. Get the full timeline:

Most recent: Clinical Trial Update: MedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR) [NA]

See pricing